MedTrace Logo

Segmentectomy vs Lobectomy

NCT06180239 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2023-12-22

No results posted yet for this study

Summary

Actual indications for stage Ia NSCLC patients suggest lobectomy and lymphadenectomy. On the other hand, recent studies reported non-inferiority of segmentectomy in case of nodule \< 2cm or with ground glass appearance at computed tomography.

However, most of these studies did not report specifical analysis on kind of segmentectomy (single or multiple) and kind of lobectomy. Moreover, a specific study on solid nodules only is still missing.

For these reasons, the effectiveness of segmentectomy instead lobectomy for every kind of segment or tumor is still to be defined.

Aim of this study is to analyze survival outcome in patients underwent single or multiple segmentectomy compared to lobectomy in stage I non small cell lung cancer.

Conditions

  • Non-small Cell Lung Cancer Stage I
  • Surgery

Sponsors & Collaborators

  • Regina Elena Cancer Institute

    collaborator OTHER

  • Istituto Europeo di Oncologia

    collaborator OTHER

  • University of Pisa

    collaborator OTHER

  • A.O.U. Città della Salute e della Scienza - Molinette Hospital

    collaborator OTHER

  • Azienda Ospedaliera "Sant'Andrea"

    collaborator OTHER

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2022-12-31
Completion
2024-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06180239 on ClinicalTrials.gov